Cognetivity Neurosciences Ltd. (CGN)

Overview

Cognetivity Neurosciences Ltd. is a technology company that specializes in the development of cognitive testing tools designed for a wide range of applications, including medical diagnosis, commercial use, and consumer wellness. Initially named Utor Capital Corp., the company underwent a name change to Cognetivity Neurosciences Ltd. in December 2017, marking a pivotal shift in its focus towards neuroscience and cognitive health. Established in 2015 and located in Vancouver, Canada, Cognetivity Neurosciences Ltd. has positioned itself as a pioneer in cognitive health technology, aiming at early diagnosis and management of cognitive impairments such as dementia.

Products and Services

• Integrated Cognitive Assessment (ICA)

The Integrated Cognitive Assessment is a hallmark product developed by Cognetivity Neurosciences Ltd. This cognitive testing platform is engineered for diverse environments, including medical settings, commercial applications, and consumer use. Its main aim is the early diagnosis of dementia by evaluating cognitive functions efficiently and accurately. The ICA tool leverages cutting-edge technology to provide rapid and reliable cognitive assessments, thereby facilitating timely intervention and care for individuals at risk of cognitive decline.

• OptiMind Wellness App

OptiMind stands out as a consumer-focused wellness application created by Cognetivity Neurosciences Ltd. Aimed at enhancing overall cognitive well-being, OptiMind provides users with daily exercises and activities designed to improve mental fitness. By incorporating a series of scientifically backed cognitive tasks, the app empowers users to monitor and enhance their cognitive health over time. Accessible and user-friendly, OptiMind reflects Cognetivity’s commitment to promoting cognitive wellness beyond the clinical setting, making it an innovative tool in the pursuit of maintaining a healthy mind.